The covalent coupling of HAV-VP3 (110-121) synthetic peptide to liposomes: Physicochemical studies

International Journal of Pharmaceutics

Volumn 269, Issue 1, 2004, Pages 177-184

  Munoz M ^a   Sospedra, P ^a   Gomara M J ^b   Mestres, C ^a   Haro, I ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

Biomembrane models; Covalently attached peptide; Hepatitis A virus; Liposomes; Monolayers; Synthetic peptides

Indexed keywords

AMPHOLYTE; ANION; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; LIPOSOME; OCTADECYLAMINE; SYNTHETIC PEPTIDE; VACCINE;

AMINO ACID SEQUENCE; ARTICLE; DRUG CONJUGATION; DRUG SYNTHESIS; HEPATITIS A VIRUS; IMMUNOGENETICS; IMMUNOGENICITY; ISOTHERM; LIPID MEMBRANE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0347418155     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.09.014     Document Type: Article

References (26)

1. Alving, C.R., 1987. In: Ostro, M.J. (Ed.), Liposomes: From Biophysics to Therapeutics. Marcel DeKKer, New York.
2. Alving C.R., Koulching V., Gleen G.M., Rao M. Liposomes as carriers of antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 145:1995;5-31.
3. Arnon R. Synthetic peptides as the basis for vaccine design. Mol. Immunol. 28:1991;209-215.
4. Bishop N.E., Anderson D.A. Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions. Arch. Virol. 142:1997;2161-2178.
5. Boeckler C., Frisch S., Muller S., Schuber F. Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides of liposomes. J. Immunol. Method. 191:1996;1-10.
6. Boeckler C., Dautel D., Schelté P., Frisch B., Wachsmann D., Klein J.P., Schuber F. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes. Eur. J. Immunol. 29:1999;2297-2308.
7. Bosch A., Gonzalez-Dankaart J.F., Haro I., Gajardo R., Perez J.A., Pinto R.M. A new continuous epitope of hepatitis A virus. J. Med. Virol. 54:1998;95-102.
8. De Frees S.A., Phillips L., Guo L., Zalipsky S. Sialyl Lewis × liposomes as a multivalent ligand and inhibitor of E-selectin mediated cellular adhesion. J. Am. Chem. Soc. 118:1996;6101-6104.
9. Galvain S., André C., Vatrinet C., Vilet B. Safety and efficacy of liposomes in specific immunotherapy. Curr. Ther. Res. 60:1999;278.
10. Garcia M., Pujol M., Reig F., Alsina M.A., Haro I. Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniques. Analyst. 121:1996;1583-1588.
11. Kung V.T., Redeman C.T. Synthesis of carboxyacyl derivates of phosphatidylethanolamine and use an efficient method for conjugation of protein to liposomes. Biochim. Biophys. Acta. 862:1986;435-439.
12. Macquaire F., Baleux F., Giaccobi E., Huynh-Dinh T., Neumann J.M., Sanson A. Peptide secondary structure induced by a micellar phospholipidic interface: proton NMR conformational study of a lipopeptide. Biochemistry. 31:1992;2576-2583.
13. Maget-Dana R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim. Biophys. Acta. 1462:1999;109-140.
14. McClare C.W. An accurate and convenient organic phosphorous assay. Anal. Biochem. Feb. 39:1971;527-530.
15. Mengiardi V., Berger R., Just M., Gluck R. Virosomes as carriers for combined vaccines. Vacine. 13:1995;1306-1315.
16. Muñoz M., Garcia M., Reig F., Alsina M.A., Haro I. Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101-121) synthetic peptide. Analyst. 123:1998;2223-2228.
17. Ono S., Lee S., Mihara H., Aoyagi H., Kato T., Yamasaki N. Design and synthesis of basic peptides having amphipathic beta-structure and their interaction with phospholipid membranes. Biochim. Biophys. Acta. 1022:1990;237-244.
18. Peetermans J. Production, quality control and characterization of an inactivated hepatitis A vaccine. Vaccine. 10:1992;S99-S101.
19. Perez J.A., Gonzalez-Dankaart J.F., Reig F., Pintó R.M., Bosch A., Haro I. Solid phase syntesis and immunogenecity of a VP3 peptide from hepatitis A virus. Biomed. Pep. Protein Nucleic Acids. 1:1995;93-100.
20. Perez J.A., Canto J., Reig F., Perez J.J., Haro I. Conformational behavior of the HAV-VP3 (110-121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods. Biopolymers. 45:1998;479-492.
21. Schelte P., Boeckler C., Frisch B., Schuber F. Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs. Bioconj. Chem. 11:2000;118-123.
22. Sospedra P., Reig F., Alsina M.A., Haro I., Mestres C. Viral synthetic peptide interaction with membranes: a monolayer study. Langmuir. 15:1999;5303-5308.
23. Vea, A., Gomara, M.J., Reig, F., Haro, I., 1998. Covalent coupling of HAV-VP3 (110-121) peptide sequence to liposomes. Effect in CD peptide spectra. In: Epton, R. (Ed.), Innovation and Perspectives in Solid Phase Synthesis and Combinatiories Chemics. Mayflower Scientific, Birmington, pp. 401-404.
24. Waassef N.M., Alving C.R., Richars R.L. Liposomes as carriers for vaccines. Immunomethods. 4:1994;217-222.
25. Woolley G.A., Deber C.M. Peptides in membranes: lipid-induced secondary structure of substance P. Biopolymers. 26:1987;109-121.
26. Yagi N., Ogawa Y., Kodaka M., Okada T., Tomohiro T., Konakahara T., Okuno H. Preparation of functional liposomes with peptide ligands and their binding to cell membranes. Lipids. 35:2000;673-680.